Why drug shortages are an ethical issue

Australasian Medical Journal

Volumn 6, Issue 11, 2013, Pages 556-559

  Lipworth, Wendy ^a,b   Kerridge, Ian ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Drug shortages; Ethics; Social consequence; Society

Indexed keywords

DRUG SHORTAGE; ETHICS; GOVERNMENT; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HUMAN; PUBLIC HEALTH SERVICE; REVIEW; SOCIAL ASPECT;

EID: 84889662561     PISSN: 18361935     EISSN: None     Source Type: Journal    
DOI: 10.4066/AMJ.2013.1869     Document Type: Review

References (29)

1. Barthelemy I, Lebel D, Bussieres J-F. Drug shortages in health care institutions: perspectives in early 2013. Can J Hosp Pharm. 2013;66(1):39-40.
2. Menees SB, Vargo JJ, Bonta C, Mayo L, Jacobson BC. Drug shortages in America: what about the gastroenterologist? Gastrointest Endosc. 2013;77(4):641-5.
3. Kweder SL, Dill S. Drug shortages: the cycle of quantity and quality. Clin Pharmacol Ther. 2013;93(3):245-51.
4. Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther. 2013;93(2):170-6.
5. Linthorst GE, Burlina AP, Cecchi F, Cox TM, Fletcher JM, Feldt-Rasmussen U, Giugliani R, Hollak CE, Houge G, Hughes D, Kantola I, Lachmann R, Lopez M, Ortiz A, Parini R, Rivera A, Rolfs A, Ramaswami U, Svarstad E, Tondel C, Tylki-Szymanska A, Vujkovac B, Waldek S, West M, Weidemann F, Mehta A. Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in Europe, following a period of shortage. JIMD Rep. 2013;8:51-6.
6. Krisl JC, Fortier CR, Taber DJ. Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinician. Am J Transplant. 2013;13(1):20-30.
7. Lynas K. Patient care and health compromised by drug shortages in Canada: survey of physicians and pharmacists. Can Pharm J. 2013;146(2):67-8.
8. Gundlapalli AV, Beekmann SE, Graham DR, Polgreen PM, and on behalf of the Infectious Diseases Society of America's Emerging Infections Network. Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists. Diagn Microbiol Infect Dis. 2013;75(3):256-9.
9. Singleton R, Chubbs K, Flynn J, Kaposy C, Peckham G, Penney J, Pullman D. From framework to the frontline: designing a structure and process for drug supply shortage planning. Healthc Manage Forum. 2013 Spring;26(1):41-5.
10. Barlas S. FDA strategies to prevent and respond to drug shortages: finding a better way to predict and prevent company closures. P T. 2013;38(5):261-3.
11. Fox ER, Tyler LS. Call to action: finding solutions for the drug shortage crisis in the United States. Clin Pharmacol Ther. 2013;93(2):145-7.
12. Houston P, Chisholm R. Water, water everywhere, but not a drop in sight: the impact of drug shortages on Canadian anesthesia care. Can J Anaesth. 2013;60(6):519-22.
13. Centers for Disease Control and Prevention (CDC). Impact of a shortage of first-line antituberculosis medication on tuberculosis control - United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2013 May 24;62(20):398-400.
14. TB drug shortage forces control programs to make onerous choices. JAMA. 2013;310(2):135.
15. Jereb J, Mase S, Chorba T, Castro K. National shortage of Purified-Protein Derivative Tuberculin products. MMWR Morb Mortal Wkly Rep. 2013;62(16):312.
16. Fairbrother G, Donauer S, Staat MA, Broder K, Salisbury S, Morrow AL, Tabangin ME, Altaye M, Holloway M, Schwartz B. Cincinnati pediatricians' measured and reported immunizing behavior for children during the national shortages of pneumococcal conjugate vaccine. Vaccine. 2013;31(17):2177-83.
17. Rider AE, Templet DJ, Daley MJ, Shuman C, Smith LV. Clinical dilemmas and a review of strategies to manage drug shortages. J Pharm Pract. 2013;26(3):183-91.
18. Daley MJ, Lat I, Kane-Gill SL. Applicability of guideline recommendations challenged in the setting of drug shortages. Crit Care Med. 2013;41(7):E143-E144.
19. Valgus J, Singer EA, Berry SR, Rathmell WK. Ethical challenges: managing oncology drug shortages. J Oncol Pract. 2013;9(2):e21-3.
20. Barr J. Applicability of guideline recommendations challenged in the setting of drug shortages: reply. Crit Care Med. 2013;41(7):E144-E5.
21. Huys I, Simoens S. European drug shortages: a call for action! Int J Pharm Pract. 2013;21(1):1-2.
22. Rosoff PM, Patel KR, Scates A, Rhea G, Bush PW, Govert JA. Coping With critical drug shortages: an ethical approach for allocating scarce resources in hospitals. Arch Intern Med. 2012;172(19):1494-9.
23. Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm. 2009;66(15):1399-1406.
24. Gibson JL, Bean S, Chidwick P, Godkin D, Sibbald RW, Wagner F. Ethical framework for resource allocation during a drug supply shortage. Healthc Q. 2012;15(3):26-35.
25. Kuehn BM. Despite curbing new drug shortages, shortfall of drugs a persistent problem. JAMA. 2013;309(6):532-3.
26. Gupta DK, Huang SM. Drug shortages in the United States: a critical evaluation of root causes and the need for action. Clin Pharmacol Ther. 2013;93(2):133-5.
27. Schweitzer SO. How the US Food and Drug Administration can solve the prescription drug shortage problem. Am J Public Health. 2013;103(5):e10-4.
28. Bedard M. Drug shortages: can we resolve that problem? Can J Anaesth. 2013;60(6):523-7.
29. Teagarden JR, Epstein RS. Pharmacy benefit managers and their obligations during serious prescription drug shortages. Clin Pharmacol Ther. 2013;93(2):143-5.